Microwave ablation is an effective treatment modality for T1a and selected T1b renal cell carcinoma (RCC). Independent of the ...

Immunotherapy has transformed the treatment landscape for lung cancer, offering significant survival benefits for patients with advanced disease. Immune checkpoint inhibitors, such as PD-1 and PD-L1 ...

product use–associated lung injury (EVALI). Among the 1139 patients with EVALI discharged on or before October 31, 2019, 31 (2.7%) were rehospitalized a median of 4 days after discharge and with ...

Complete ablation was reached in 72% (95% CI ... including breast, kidney, lung, and liver. ProSense® enhances patient and provider value by accelerating recovery, reducing pain, surgical ...

"Optimized through ablation studies, self-attention mechanisms, and efficient training, ECgMLP generalizes well across multiple histopathology datasets, thereby making it a robust and clinically ...

Percutaneous ablation therapies currently play a major role in the management of T1a and T1b renal cell carcinoma (RCC). These therapies include thermal ablative technologies like radiofrequency (RFA) ...